Last Posted: Jul 24, 2020
- Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.
Chae Young Kwang et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 14(10) 1807-1817 - Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer.
Kolarova Iveta et al. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2019 Dec 163(4) 285-292 - Cancer immunotherapy comes of age and looks for maturity
A Finck, et al Nat Comms, July 20, 2020 - Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
Xu Ning et al. Cancer cell international 2020 20302 - Circulating biomarkers predictive of tumor response to cancer immunotherapy.
Lee Ernest Y et al. Expert review of molecular diagnostics 2019 19(10) 895-904 - Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
Kim Hong Sook et al. European journal of cancer (Oxford, England : 1990) 2019 12065-74 - A New FDA Approval Furthers the Role of Genomics in Cancer Care
NCI Director blog, July 8, 2020 - Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine.
Dai Xiaofeng et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2020 Jun 7(12) 1902552 - Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board.
Bernhardt Erica B et al. Practical laboratory medicine 2020 Aug 21e00174 - Global molecular diversity of RSV - the "INFORM RSV" study.
Langedijk Annefleur C et al. BMC infectious diseases 2020 Jun (1) 450
.png)
No hay comentarios:
Publicar un comentario